13 February 2017Americas

Federal Circuit reverses infringement ruling in Shire v Watson

The US Court of Appeals for the Federal Circuit has reversed and remanded a decision by a district court centring on the drug Lialda (mesalamine), a treatment for ulcerative colitis.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Jones Day adds in-house biologics specialist to Boston office

20 May 2026 The firm brings in a former VP at a biotech company, with biologics experience across antibodies, antibody drug-conjugates, peptides and gene and cell therapies.

Americas

Kirkland & Ellis subject of alleged conflict in trade secrets clash

19 May 2026 In the firm’s second IP conflict dispute in a year, a healthcare tech company claims Kirkland lawyers "committed the cardinal sin of trying to represent the conflicting interests of opposing parties".

Americas

Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme

19 May 2026 The award could rise to several billions under federal antitrust law, after the pharma company was found to have engaged in anticompetitive conduct over constipation drug Amitiza.